[
  {
    "ts": null,
    "headline": "Elevance Health Inc. stock outperforms competitors on strong trading day",
    "summary": "Elevance Health Inc. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=28a4ca95742400aaaa9f8eff7045d8d247c9abe0630b489a41bd5ece91ddecb0",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736268240,
      "headline": "Elevance Health Inc. stock outperforms competitors on strong trading day",
      "id": 132326250,
      "image": "",
      "related": "ELV",
      "source": "MarketWatch",
      "summary": "Elevance Health Inc. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=28a4ca95742400aaaa9f8eff7045d8d247c9abe0630b489a41bd5ece91ddecb0"
    }
  },
  {
    "ts": null,
    "headline": "Is Now An Opportune Moment To Examine Elevance Health, Inc. (NYSE:ELV)?",
    "summary": "Elevance Health, Inc. ( NYSE:ELV ) received a lot of attention from a substantial price movement on the NYSE over the...",
    "url": "https://finnhub.io/api/news?id=3f6e85d1b43389f2982e116759df858e0ffbc8db1bfd66c46b60f54d6b564085",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736258431,
      "headline": "Is Now An Opportune Moment To Examine Elevance Health, Inc. (NYSE:ELV)?",
      "id": 132313829,
      "image": "https://media.zenfs.com/en/simply_wall_st__316/51205512c711d77f69d43f584dc913e4",
      "related": "ELV",
      "source": "Yahoo",
      "summary": "Elevance Health, Inc. ( NYSE:ELV ) received a lot of attention from a substantial price movement on the NYSE over the...",
      "url": "https://finnhub.io/api/news?id=3f6e85d1b43389f2982e116759df858e0ffbc8db1bfd66c46b60f54d6b564085"
    }
  },
  {
    "ts": null,
    "headline": "Elevance Health price target lowered to $480 from $520 at Truist",
    "summary": "Truist lowered the firm’s price target on Elevance Health (ELV) to $480 from $520 and keeps a Buy rating on the shares as part of a broader research note previewing 2025 for Healthcare Services. The firm sees the outlook for the group as “mixed”, with bullish stance on the underlying demand drivers and overarching sector tailwinds that include demographics, value-based care, and core demand being offset by heightened concern around a likely more cost focused government backdrop. Selectivity is k",
    "url": "https://finnhub.io/api/news?id=5c6fa0911704e4cb648ca5f321f3295bf98807f4f487a1d81c0a08d31fce59cd",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736254677,
      "headline": "Elevance Health price target lowered to $480 from $520 at Truist",
      "id": 132299637,
      "image": "",
      "related": "ELV",
      "source": "Yahoo",
      "summary": "Truist lowered the firm’s price target on Elevance Health (ELV) to $480 from $520 and keeps a Buy rating on the shares as part of a broader research note previewing 2025 for Healthcare Services. The firm sees the outlook for the group as “mixed”, with bullish stance on the underlying demand drivers and overarching sector tailwinds that include demographics, value-based care, and core demand being offset by heightened concern around a likely more cost focused government backdrop. Selectivity is k",
      "url": "https://finnhub.io/api/news?id=5c6fa0911704e4cb648ca5f321f3295bf98807f4f487a1d81c0a08d31fce59cd"
    }
  }
]